Aug. 19 at 9:09 AM
$ALMU $XE $KURA $COHR ALMU remains highly speculative, XE remains execution-dependent, Kura Oncology advances targeted cancer therapies, and Coherent benefits from optical, AI-networking, and semiconductor demand. I'm watching funding, clinical milestones, AI infrastructure, and order growth.